This inventor holds 1 USPTO granted patent. Top assignees: Assistance Publique-Hopitaux De Paris, Centre National De La Recherche Scientifique, Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet). Active years: 2017.
Company Filing History:
1 out of 331 
1 out of 5,383 
1 out of 81 
Years Active: 2017
Title: Hugo Daniel Luján: Innovator in Pharmaceutical Compositions
Introduction
Hugo Daniel Luján is a notable inventor based in Córdoba, Argentina. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent that focuses on enhancing immune responses.
Latest Patents
Luján holds a patent for "Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereof." This invention relates to pharmaceutical compositions that utilize a polypeptide with at least one CXXC motif, such as parasite's variable surface proteins (VSP) or fragments thereof. The aim is to raise an immune response against selected heterologous antigens, including tumor and microbial antigens, through oral or mucosal vaccination.
Career Highlights
Throughout his career, Luján has worked with prestigious institutions, including the Centre National de la Recherche Scientifique and Université Pierre et Marie Curie (Paris 6). His work has been instrumental in advancing the understanding of immune responses and their applications in medicine.
Collaborations
Luján has collaborated with esteemed colleagues such as David Klatzmann and Eliane Piaggio. Their joint efforts have contributed to the development of innovative solutions in the pharmaceutical field.
Conclusion
Hugo Daniel Luján is a prominent figure in the realm of pharmaceutical innovations. His work continues to influence the development of effective vaccination strategies and immune response enhancement.